| pubmed-article:9191545 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9191545 | lifeskim:mentions | umls-concept:C0037663 | lld:lifeskim |
| pubmed-article:9191545 | lifeskim:mentions | umls-concept:C0597298 | lld:lifeskim |
| pubmed-article:9191545 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
| pubmed-article:9191545 | lifeskim:mentions | umls-concept:C0074898 | lld:lifeskim |
| pubmed-article:9191545 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:9191545 | lifeskim:mentions | umls-concept:C0038135 | lld:lifeskim |
| pubmed-article:9191545 | pubmed:issue | 6 Pt 1 | lld:pubmed |
| pubmed-article:9191545 | pubmed:dateCreated | 1997-7-14 | lld:pubmed |
| pubmed-article:9191545 | pubmed:abstractText | The impact of the adoption of the new biosynthetic growth hormone (GH) WHO International Reference Preparation (IRP 88/624), and the recommendation to report results in microgram/L instead of mU/L, is described. Conversion factors were determined by comparing both the linear and nonlinear relations of the GH values. The Pharmacia polyclonal IRMA (p-IRMA) and the DELFIA monoclonal time-resolved immunofluorometric assay (trIFMA) with kit calibrators calibrated either against the pituitary-derived WHO IRP 80/505 or the new 88/624 were evaluated. Conversion factors of 4.17 mU/L = 1 microgram/L for the p-IRMA and 4.31 mU/L = 1 microgram/L for the trIFMA were necessary. Different cross-reactivity patterns for the deaminated and dimer 22-kDa, 20-kDa, and 17-kDa GH isoforms were found. Expected GH recovery was similar when the measured values were adjusted according to the results of the cross-reactivity study. | lld:pubmed |
| pubmed-article:9191545 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9191545 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9191545 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9191545 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9191545 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9191545 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9191545 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9191545 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9191545 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9191545 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9191545 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:9191545 | pubmed:issn | 0009-9147 | lld:pubmed |
| pubmed-article:9191545 | pubmed:author | pubmed-author:RosbergSS | lld:pubmed |
| pubmed-article:9191545 | pubmed:author | pubmed-author:CarlssonLL | lld:pubmed |
| pubmed-article:9191545 | pubmed:author | pubmed-author:Albertsson-Wi... | lld:pubmed |
| pubmed-article:9191545 | pubmed:author | pubmed-author:JanssonCC | lld:pubmed |
| pubmed-article:9191545 | pubmed:author | pubmed-author:BoguszewskiCC | lld:pubmed |
| pubmed-article:9191545 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9191545 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:9191545 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9191545 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9191545 | pubmed:pagination | 950-6 | lld:pubmed |
| pubmed-article:9191545 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:meshHeading | pubmed-meshheading:9191545-... | lld:pubmed |
| pubmed-article:9191545 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9191545 | pubmed:articleTitle | Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. | lld:pubmed |
| pubmed-article:9191545 | pubmed:affiliation | Department of Pediatrics, University of Göteborg, Sweden. chatarina.jansson@pediat.gu.se | lld:pubmed |
| pubmed-article:9191545 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9191545 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9191545 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9191545 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9191545 | lld:pubmed |
